Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Ferrer

Showing results (101-110 of 293) with videos related to

Pageof 30
Sort By:
Autophagy|February 27, 2019
A family of PIKFYVE inhibitors with therapeutic potential against autophagy-dependent cancer cells disrupt multiple events in lysosome homeostasisGaurav Sharma, Carlos M Guardia, Ajit Roy, et al.
Cancer Letters|August 29, 2017
Manumycin A suppresses exosome biogenesis and secretion via targeted inhibition of Ras/Raf/ERK1/2 signaling and hnRNP H1 in castration-resistant prostate cancer cellsAmrita Datta, Hogyoung Kim, Madhu Lal, et al.
Scientific Reports|September 17, 2017
Identification of 4-phenylquinolin-2(1H)-one as a specific allosteric inhibitor of AktBill X Huang, Kenny Newcomer, Karl Kevala, et al.
Plos One|January 24, 2013
Inhibition of ceramide metabolism sensitizes human leukemia cells to inhibition of BCL2-like proteinsLavona Casson, Lauren Howell, Lesley A Mathews, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2016
Augmented efficacy of brentuximab vedotin combined with ruxolitinib and/or Navitoclax in a murine model of human Hodgkin's lymphomaWei Ju, Meili Zhang, Kelli M Wilson, et al.
Frontiers in Psychiatry|January 26, 2023
Severity in the ICD-11 personality disorder model: Evaluation in a Spanish mixed sampleFernando Gutiérrez, Anton Aluja, Claudia Rodríguez, et al.
ACS Chemical Biology|October 7, 2011
Parsimonious discovery of synergistic drug combinationsBryan Severyn, Robert A Liehr, Alex Wolicki, et al.
Journal of Biomolecular Screening|April 17, 2007
The use of strictly standardized mean difference for hit selection in primary RNA interference high-throughput screening experimentsXiaohua Douglas Zhang, Marc Ferrer, Amy S Espeseth, et al.
Plos One|April 5, 2014
High-throughput screening for the identification of new therapeutic options for metastatic pheochromocytoma and paragangliomaAlessio Giubellino, Uma Shankavaram, Petra Bullova, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2017
Discovery of a Positive Allosteric Modulator of the Thyrotropin Receptor: Potentiation of Thyrotropin-Mediated Preosteoblast Differentiation In VitroSusanne Neumann, Elena Eliseeva, Alisa Boutin, et al.
Pageof 30

Showing results (101-110 of 293) with videos related to

Sort By:
Pageof 30
Autophagy|February 27, 2019
A family of PIKFYVE inhibitors with therapeutic potential against autophagy-dependent cancer cells disrupt multiple events in lysosome homeostasisGaurav Sharma, Carlos M Guardia, Ajit Roy, et al.
Cancer Letters|August 29, 2017
Manumycin A suppresses exosome biogenesis and secretion via targeted inhibition of Ras/Raf/ERK1/2 signaling and hnRNP H1 in castration-resistant prostate cancer cellsAmrita Datta, Hogyoung Kim, Madhu Lal, et al.
Scientific Reports|September 17, 2017
Identification of 4-phenylquinolin-2(1H)-one as a specific allosteric inhibitor of AktBill X Huang, Kenny Newcomer, Karl Kevala, et al.
Plos One|January 24, 2013
Inhibition of ceramide metabolism sensitizes human leukemia cells to inhibition of BCL2-like proteinsLavona Casson, Lauren Howell, Lesley A Mathews, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2016
Augmented efficacy of brentuximab vedotin combined with ruxolitinib and/or Navitoclax in a murine model of human Hodgkin's lymphomaWei Ju, Meili Zhang, Kelli M Wilson, et al.
Frontiers in Psychiatry|January 26, 2023
Severity in the ICD-11 personality disorder model: Evaluation in a Spanish mixed sampleFernando Gutiérrez, Anton Aluja, Claudia Rodríguez, et al.
ACS Chemical Biology|October 7, 2011
Parsimonious discovery of synergistic drug combinationsBryan Severyn, Robert A Liehr, Alex Wolicki, et al.
Journal of Biomolecular Screening|April 17, 2007
The use of strictly standardized mean difference for hit selection in primary RNA interference high-throughput screening experimentsXiaohua Douglas Zhang, Marc Ferrer, Amy S Espeseth, et al.
Plos One|April 5, 2014
High-throughput screening for the identification of new therapeutic options for metastatic pheochromocytoma and paragangliomaAlessio Giubellino, Uma Shankavaram, Petra Bullova, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2017
Discovery of a Positive Allosteric Modulator of the Thyrotropin Receptor: Potentiation of Thyrotropin-Mediated Preosteoblast Differentiation In VitroSusanne Neumann, Elena Eliseeva, Alisa Boutin, et al.
Pageof 30